SILO PHARMA, INC. Payments of Stock Issuance Costs
SILO PHARMA, INC. (SILO) reported Payments of Stock Issuance Costs of $406.04 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- SILO PHARMA, INC. payments of stock issuance costs for the quarter ending 2025-06-30 was $406.04K.
- SILO PHARMA, INC. payments of stock issuance costs for fiscal 2013 was $198.05K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2026-06-30 | $406.04K 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $774.71K POS AM · filed 2026-04-14 | ||
| 2025-06-30 | $406.04K 10-Q · filed 2025-11-13 | ||
| 2013-12-31 | $198.05K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |